Home > Boards > US Listed > Medical - Drugs >

Valeant Pharmaceuticals International (VRX)

VRX RSS Feed
Add VRX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 4/23/2014 2:33:57 PM - Followers: 7 - Board type: Free - Posts Today: 0
http://www.valeant.com/ http://finance.yahoo.com/q/ks?s=VRX Valeant Pharmaceuticals International, a specialty pharmaceutical company, engages in the development, manufacture, and marketing of a range of pharmaceutical products. It primarily offers prescription pharmaceutical products in the areas of neurology, dermatology, and infectious diseases. The company's neurology products include Diastat and Diastat AcuDial, Mestinon, Cesamet, Librax, Dalmane/Dalmadorm, Migranal, Tasmar, Melleril, and Zelapar. Its dermatology products comprise Efudex/Efudix, Kinerase, Oxsoralen-Ultra, and Dermatix. The company also offers various infectious disease products, such as Virazole, the brand name for ribavirin; and other therapeutic products, including Bedoyecta, Solcoseryl, Bisocard, M.V.I., Nyal, Espaven, and Protamin. In addition, Valeant Pharmaceuticals provides products in the areas of neuromuscular disorders, cancer, cardiovascular disease, diabetes, and psychiatric disorders. As of December 31, 2007, its product portfolio comprised approximately 352 branded products, with approximately 1,974 stock keeping units. The company markets its pharmaceutical products to physicians, hospitals, pharmacies, and wholesalers through its sales force, as well as through wholesalers in the United States, Mexico, Poland, Canada, and Germany. Valeant Pharmaceuticals was founded in 1960 and is headquartered in Aliso Viejo, California.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VRX
Current Price
Volume:
Bid Ask Day's Range
Wiki
Option Chain for VRX
VRX News: Current Report Filing (8-k) 06:16 AM
VRX News: Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 06:00 AM
VRX News: Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 06:00 AM
VRX News: Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) 07/30/2014 05:21:36 PM
VRX News: Statement of Changes in Beneficial Ownership (4) 07/30/2014 05:19:26 PM
News News Alert: Current Report Filing (8-k) 07/31/2014 06:16:15 AM
PostSubject
#13   Good piece from the NYT on the prosposed DewDiligence 04/23/14 02:33:57 PM
#12   Congrat$ here!! Abondanceinvest 04/22/14 09:21:08 AM
#11   Presentation updates- Goldman-Sachs-34th-Annual-Global-Healthcare-Conference ECole 07/25/13 08:22:52 AM
#10   VRX raise its offer for mlkrborn 09/26/11 07:35:20 PM
#9   Also, Valeant and GlaxoSmithKline say today that the mlkrborn 06/13/11 01:28:27 PM
#8   Valeant Pharmaceuticals and GlaxoSmithKline (GSK) receive FDA approval mlkrborn 06/13/11 01:09:11 PM
#7   8:08AM Valeant Pharmaceuticals beats by $0.05, beats on mlkrborn 05/09/11 06:06:43 PM
#6   10:09 am VRX Discusses Integration Plans (VRX) mlkrborn 09/07/10 06:59:04 PM
#5   Valeant Pharmaceuticals VRX Jefferies & Co Buy $49 surf1944 02/05/10 09:13:20 AM
#4   Valeant Pharmaceuticals International Q2 2008 Earnings Call Transcrip surf1944 08/13/08 10:19:57 PM
#3   Valeant posts 2nd-quarter loss as sales slip surf1944 08/13/08 10:19:23 PM
#2   Valeant Pharmaceuticals to redeem 7 percent notes surf1944 06/25/08 08:41:40 AM
#1   Valeant says FDA stays approval of competing drug surf1944 05/15/08 09:31:04 AM
PostSubject